Community Series in the Role of CD1- and MR1-restricted T cells in Immunity and Disease, volume II

47.1K
views
87
authors
18
articles
Editors
2
Impact
Loading...

Mucosal-associated invariant T (MAIT) cells play diverse roles in cancer, infectious diseases, and immunotherapy. This review explores their intricate involvement in cancer, from early detection to their dual functions in promoting inflammation and mediating anti-tumor responses. Within the solid tumor microenvironment (TME), MAIT cells can acquire an ‘exhausted’ state and secrete tumor-promoting cytokines. On the other hand, MAIT cells are highly cytotoxic, and there is evidence that they may have an anti-tumor immune response. The frequency of MAIT cells and their subsets has also been shown to have prognostic value in several cancer types. Recent innovative approaches, such as programming MAIT cells with chimeric antigen receptors (CARs), provide a novel and exciting approach to utilizing these cells in cell-based cancer immunotherapy. Because MAIT cells have a restricted T cell receptor (TCR) and recognize a common antigen, this also mitigates potential graft-versus-host disease (GVHD) and opens the possibility of using allogeneic MAIT cells as off-the-shelf cell therapies in cancer. Additionally, we outline the interactions of MAIT cells with the microbiome and their critical role in infectious diseases and how this may impact the tumor responses of these cells. Understanding these complex roles can lead to novel therapeutic strategies harnessing the targeting capabilities of MAIT cells.

4,370 views
5 citations
2,902 views
5 citations
(A) Stimulating iNKT cells with α-GalCer or its analog can either reduce Th1 response or improve Th2 response, potentiate MDSC or M2 macrophage differentiation to improve EAE outcomes. High doses of α-GalCer selectively increase Th1 and Th17 responses to exacerbate EAE progression. Sulfatide activates type II NKT cells, which suppress IFN-γ and IL-4 production by pathogenetic antigen-reactive T cells and protect mice from EAE. (B) IL-17-producing γδ T cells exacerbate EAE progression by increasing inflammation by not only promoting Th17 cell function but also restraining the generation of Tregs. IFNγ-producing γδ T cells suppress the activity of Th17 cells and release chemokines to recruit Treg cells to reduce inflammatory signals. Moreover, γδ T cells can induce the apoptosis of encephalitogenic T cells through Fas/Fas ligand signaling and facilitate recovery from EAE. (C) MAIT cells alleviate the progression of EAE by decreasing inflammatory mediators and increasing IL-10 production. MDSC, myeloid-derived suppressor cell; EAE, experimental autoimmune encephalomyelitis; Treg, regulatory T cells.
3,904 views
14 citations
Article Cover Image
Review
25 September 2023

Chronic tissue inflammation often results in fibrosis characterized by the accumulation of extracellular matrix components remodeling normal tissue architecture and function. Recent studies have suggested common immune mechanisms despite the complexity of the interactions between tissue-specific fibroblasts, macrophages, and distinct immune cell populations that mediate fibrosis in various tissues. Natural killer T (NKT) cells recognizing lipid antigens bound to CD1d molecules have been shown to play an important role in chronic inflammation and fibrosis. Here we review recent data in both experimental models and in humans that suggest a key role of type 1 invariant NKT (iNKT) cell activation in the progression of inflammatory cascades leading to recruitment of neutrophils and activation of the inflammasome, macrophages, fibroblasts, and, ultimately, fibrosis. Emerging evidence suggests that iNKT-associated mechanisms contribute to type 1, type 2 and type 3 immune pathways mediating tissue fibrosis, including idiopathic pulmonary fibrosis (IPF). Thus, targeting a pathway upstream of these immune mechanisms, such as the inhibition of iNKT activation, may be important in modulating various fibrotic conditions.

6,831 views
10 citations
Recommended Research Topics
Frontiers Logo

Frontiers in Immunology

CD1- and MR1-restricted T Cells in Antimicrobial Immunity
Edited by S.M. Mansour Haeryfar, Thierry Mallevaey
153.9K
views
47
authors
18
articles
Frontiers Logo

Frontiers in Immunology

Role of CD1- and MR1-restricted T cells in Immunity and Disease
Edited by Kazuya Iwabuchi, Luc Van Kaer
310.7K
views
163
authors
41
articles
24.3K
views
41
authors
5
articles
Frontiers Logo

Frontiers in Immunology

MAIT Cells Come of Age
Edited by Alexandra Jane Corbett, Timothy Stopford Christopher Hinks, James E. Ussher
46.7K
views
61
authors
9
articles
Deadline
31 Oct 2023
Submit